TY - JOUR
T1 - Brain oxidation is an initial process in sleep induction
AU - Ikeda, M.
AU - Ikeda-Sagara, M.
AU - Okada, T.
AU - Clement, P.
AU - Urade, Y.
AU - Nagai, T.
AU - Sugiyama, T.
AU - Yoshioka, T.
AU - Honda, K.
AU - Inoué, S.
N1 - Funding Information:
We thank Shigeko Matsumoto and Nanae Nagata (Osaka Bioscience Institute) for technical assistance. The Cameleon cDNA was a gift from Dr. Atsushi Miyawaki (RIKEN) and the neuron-specific enolase promoter was a gift from Dr. Kenji Sakimura (Nigata University). This work was supported in part by a Grant-in-Aid for Scientific Research of Japan Society for the Promotion of Science (B16300104) to M.I., Special Coordination Funds for Promoting Science and Technology by the Ministry of Education, Culture, Sports, Science and Technology Japan, to M.I. and Y.U., and a grant from Takeda Science Foundation to M.I. and P.C.
PY - 2005
Y1 - 2005
N2 - CNS activity is generally coupled to the vigilance state, being primarily active during wakefulness and primarily inactive during deep sleep. During periods of high neuronal activity, a significant volume of oxygen is used to maintain neuronal membrane potentials, which subsequently produces cytotoxic reactive oxygen species (ROS). Glutathione, a major endogenous antioxidant, is an important factor protecting against ROS-mediated neuronal degeneration. Glutathione has also been proposed to be a sleep-promoting substance, yet the relationship between sleep and cerebral oxidation remains unclear. Here we report that i.c.v. infusion of the organic peroxide t-butyl-hydroperoxide at a concentration below that triggering neurodegeneration (0.1 μmol/100 μl/10 h) promotes sleep in rats. Also, microinjection (2 nmol, 2 μl) or microdialysis (100 μM, 20 min) of t-butyl-hydroperoxide into the preoptic/anterior hypothalamus (POAH) induces the release of the sleep-inducing neuromodulators, nitric oxide and adenosine, without causing neurodegeneration. Nitric oxide and adenosine release was inhibited by co-dialysis of the N-methyl-d-aspartate receptor antagonist, d(-)-2-amino-5-phosphonopentanoic acid (D-AP5; 1 mM), suggesting that glutamate-induced neuronal excitation mediates the peroxide-induced release of nitric oxide and adenosine. Indeed, Ca 2+ release from mitochondria and delayed-onset Ca 2+ influx via N-methyl-d-aspartate receptors was visualized during peroxide exposure using Ca 2+ indicator proteins (YC-2.1 and mitochondrial-targeted Pericam) expressed in organotypic cultures of the POAH. In the in vitro models, t-butyl-hydroperoxide (50 μM) causes dendritic swelling followed by the intracellular Ca 2+ mobilization, and D-AP5 (100 μM) or glutathione (500 μM) inhibited t-butyl-hydroperoxide-induced intracellular Ca 2+ mobilization and protected POAH neurons from oxidative stress. These data suggest that low-level subcortical oxidation under the control of an antioxidant system may trigger sleep via the Ca 2+-dependent release of sleep-inducing neuromodulators in the POAH, and thus we propose that a moderate increase of ROS during wakefulness in the neuronal circuits regulating sleep may be an initial trigger in sleep induction.
AB - CNS activity is generally coupled to the vigilance state, being primarily active during wakefulness and primarily inactive during deep sleep. During periods of high neuronal activity, a significant volume of oxygen is used to maintain neuronal membrane potentials, which subsequently produces cytotoxic reactive oxygen species (ROS). Glutathione, a major endogenous antioxidant, is an important factor protecting against ROS-mediated neuronal degeneration. Glutathione has also been proposed to be a sleep-promoting substance, yet the relationship between sleep and cerebral oxidation remains unclear. Here we report that i.c.v. infusion of the organic peroxide t-butyl-hydroperoxide at a concentration below that triggering neurodegeneration (0.1 μmol/100 μl/10 h) promotes sleep in rats. Also, microinjection (2 nmol, 2 μl) or microdialysis (100 μM, 20 min) of t-butyl-hydroperoxide into the preoptic/anterior hypothalamus (POAH) induces the release of the sleep-inducing neuromodulators, nitric oxide and adenosine, without causing neurodegeneration. Nitric oxide and adenosine release was inhibited by co-dialysis of the N-methyl-d-aspartate receptor antagonist, d(-)-2-amino-5-phosphonopentanoic acid (D-AP5; 1 mM), suggesting that glutamate-induced neuronal excitation mediates the peroxide-induced release of nitric oxide and adenosine. Indeed, Ca 2+ release from mitochondria and delayed-onset Ca 2+ influx via N-methyl-d-aspartate receptors was visualized during peroxide exposure using Ca 2+ indicator proteins (YC-2.1 and mitochondrial-targeted Pericam) expressed in organotypic cultures of the POAH. In the in vitro models, t-butyl-hydroperoxide (50 μM) causes dendritic swelling followed by the intracellular Ca 2+ mobilization, and D-AP5 (100 μM) or glutathione (500 μM) inhibited t-butyl-hydroperoxide-induced intracellular Ca 2+ mobilization and protected POAH neurons from oxidative stress. These data suggest that low-level subcortical oxidation under the control of an antioxidant system may trigger sleep via the Ca 2+-dependent release of sleep-inducing neuromodulators in the POAH, and thus we propose that a moderate increase of ROS during wakefulness in the neuronal circuits regulating sleep may be an initial trigger in sleep induction.
KW - brain dialysis
KW - free radicals
KW - microtubule-associated protein 2
KW - neurodegenerative disorders
KW - reactive oxygen species
KW - sleep homeostasis
UR - http://www.scopus.com/inward/record.url?scp=19944429973&partnerID=8YFLogxK
U2 - 10.1016/j.neuroscience.2004.09.057
DO - 10.1016/j.neuroscience.2004.09.057
M3 - 学術論文
C2 - 15652998
AN - SCOPUS:19944429973
SN - 0306-4522
VL - 130
SP - 1029
EP - 1040
JO - Neuroscience
JF - Neuroscience
IS - 4
ER -